Cardinal will beef up its direct-to-home distribution channels
Cardinal is paying $2.07 billion for the privately held company, which it says had 2012 sales of about $1 billion, including the recently acquired Invacare Supply Group. AssuraMed operates through two separate businesses, Independence Medical and Edgepark Medical Supplies.
Besides building on its massive healthcare distribution network already in place, Cardinal says that “AssuraMed’s expertise in products for specific disease categories and small parcel logistics will significantly enhance Cardinal Health’s ability to service customers across the broad ambulatory care channel, including care sites such as physician offices and in support of home health agencies.” Eventually, says the company, it will supply the home healthcare channel with product lines including ostomy, diabetes, insulin therapy, urological, wound care and incontinence; and to use this acquisition as a platform to begin offering a variety of its current house-brand product offerings in the direct-to-home channel.
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.